İçeriğe geç

The Lancet Diabetes & Endocrinology

@thelancetendo.bsky.social did:plc:b4o27tf7dzv6yrxdoevn7qtz

Your leading source of international, cutting-edge research, review, and opinion in clinical #diabetes and #endocrinology. IF=36·3. 🌐 thelancet.com/journals/landia/home

Bluesky’a katılma tarihi:

Takipçi
1.864
Takip edilen
751
Post
1.292
Sıralamaya girdiği gün
0

Özet

The Lancet Diabetes & Endocrinology (@thelancetendo.bsky.social), 3 Şubat 2025 tarihinde katılan bir Bluesky kullanıcısı. 1.864 takipçisi var, 751 hesabı takip ediyor ve 1.292 post paylaştı.

Sıralama geçmişi

Bu hesabın postlarının Debya günlük listesine girdiği en iyi günler.

Bu hesap henüz günlük sıralamaya girmedi.

Son beğendiği postlar

Bluesky ağındaki herkese açık beğeniler.

  • European Association for the Study of Diabetes@easdnews.bsky.social

    🔬 Don’t miss this important session! Join Prof. Chantal Mathieu for a Lab Talk at #EASD2026. 📅 2 Oct |🕙10:15 - 10:45 CEST | 📍 Arena Hear about her #lab, her #research & how she leads her team. Make sure to join the conversation in the Arena! It's going to be a great one! #Diabetes #LabTalk

    Postu göster
  • European Association for the Study of Diabetes@easdnews.bsky.social

    🔴 Happening now at #EASD2026. Today's session draws on insights from a major Phase 3 efficacy trial: TRIUMPH-2 of retatrutide in people with obesity & T2D with: 🎤 John Wilding 🎤 Juan Pablo Frias 🎤 Elif Ekinci 🎤 Elisabeth Van Rossum Chaired by Arya M. Sharma 📍 Happening now in the Paris Hall

    Postu göster
  • European Association for the Study of Diabetes@easdnews.bsky.social

    Early detection saves lives. EU Commissioner Olivér Várhelyi launched the “#KnowYourNumbers” campaign for the first-ever #EUScreeningWeek. @easdnews.bsky.social, @escardio.bsky.social,@easoobesity.bsky.social &@eudiabetesforum.bsky.social welcome the proposal. 👉 health.ec.europa.eu/know-your-nu...

    Postu göster
  • NIHR ARC East Midlands@arc-em.bsky.social

    A new framework published today in @thelancetendo.bsky.social sets out 35 core outcomes for testing interventions to modify the progression of #type2diabetes. Researchers from @arc-em.bsky.social and @uniofleicester.bsky.social are part of the team behind it. 🔗 arc-em.nihr.ac.uk/news/type-2-...

    Postu göster
  • Will Herrington@willkidney.bsky.social

    Almost all u need 2 know about the remarkable clinical effects of #SGLT2i on the kidney in a wide ranging IPD metaanalysis (covers effects by albuminuria, predicted eGFR dip and novel exploratory eGFR slope methods). Please do read it! @oxpop.bsky.social @martinlandray.bsky.social

    Postu göster

Daha fazlası için üye girişi yap

Blokladığı hesaplar

Bluesky’da bloklar herkese açık kayıtlardır.

Bu hesap kimseyi bloklamıyor.